Scottsdale 3/30/2012 3:35:00 AM
News / Finance

Nutrastar International, Inc. (NUIN) Posts Full-year 2011 Financial Results, Achieves Record Sales

QualityStocks would like to highlight Nutrastar International, Inc. (OTCBB: NUIN), a leading China-based producer and supplier of premium branded consumer products, including commercially cultivated Cordyceps Militaris, functional health beverages, and organic and specialty food products. Cordyceps Militaris, their core product, is one of the most highly regarded herbal nutrients in Traditional Chinese Medicine. The company is headquartered in Harbin, capital of Heilongjiang province, with 321 employees, including 21 in R&D and 140 in sales and marketing. The products of Nutrastar are sold throughout China via a direct and distribution network covering more than 10 provinces.

In the company’s news yesterday,

Nutrastar International announced financial results for the year ended December 31, 2011.

Revenues increased 41.1 percent to $34.21 million compared to $24.24 million in the year ended December 31, 2010.

Gross profit increased 32.4 percent to $25.96 million, up from $19.6 million in the comparable 2010 year, representing a gross margin of 75.9 percent.

Net income rose 26.3 percent to $17.00 million, or basic and diluted earnings per share of $1.12 and $1.04, respectively, up from $13.44 million reported for full year 2010, representing a net margin of 49.7 percent.

As of December 31, 2011, Nutrastar had cash and cash equivalents totaling $54.56 million, or $3.34 per diluted share; total assets of approximately $76.43 million, or $4.68 per diluted share; working capital of $52.33 million, or $3.20 per diluted share; and stockholders’ equity of $72.02 million. Net cash generated from operating activities was $18.80 million for the year ended December 31, 2011, as compared to $15.35 million in the comparable 2010 period.

The company attributes its record sales to strong Chinese consumer demand, as well as an effective marketing campaign.

“As a result of our marketing and branding efforts, our functional health beverages saw sales grow to $6.85 million for 2011 with $3.38 million in sales recorded in the fourth quarter alone, up 60 percent from third quarter sales of $2.11 million,” Lianyun Han, CEO of Nutrastar, stated in the press release. “While still high, gross margins declined to 75.9 percent from 80.9 percent in 2010 due to the increased contribution of our beverage products which incur a higher cost of production than our core consumer product, Cordyceps.”

Han said the company is diversifying its product offerings with the addition an instant soluble drink powder as well as several organic products.

The company reaffirmed guidance that 2012 revenue will be in the range of $40 million to $44 million, representing an approximate 17 percent to 29 percent top line increase year-over-year.

About QualityStocks

QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.

To sign up for The QualityStocks Daily Newsletter, please visit www.QualityStocks.net 

Please read FULL disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.net  

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.